Vertex Pharmaceuticals Incorporated (VRTX) Price Forecast — AI Targets | MarketCI

Vertex Pharmaceuticals Incorporated (VRTX) Price Forecast — AI Targets | MarketCI | MarketCI

VRTX

Market Closed

Vertex Pharmaceuticals Incorporated

NASDAQHealthcare Biotechnology

6.40K employees

CEO: Reshma Kewalramani

Founded: 1991

$496.07

+$0.00(+NaN%)

Market Cap

125.91B

Beta

0.29

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

The AI 30-day forecast is trending modestly downside, indicating short-term risk. Analyst consensus is broadly aligned with strong coverage and moderate spread, suggesting relatively stable long-term outlook confidence. This combination reveals a cautious near-term environment amid sustained positive analyst sentiment.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for VRTX

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore VRTX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

VRTX in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →